Search

everythinglearnresearchcommunity

for

Search:↓

Magnesium oxide-infused membranes help heal wounds faster by reducing inflammation and promoting skin and hair follicle growth.

Vitamin D made by the skin plays a role in immune defense and skin health, and more research is needed to understand its full effects.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Psoriasis or contact dermatitis can override alopecia areata, allowing hair growth.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Prolactin may be important for skin growth and immune function.

Lowering testosterone speeds up wound healing in male mice.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

The document explains various skin conditions and their treatments.

TNF-alpha inhibitors can cause various immune-related skin issues.

Immune changes and specific genes contribute to male hair loss.

Aging causes skin stem cells to work less effectively.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

CD2 might be a new treatment target for patchy alopecia areata.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.